BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 714689)

  • 1. [Prediction of aminoglycoside nephrotoxicity (author's transl)].
    Whelton A
    Nouv Presse Med; 1978 Nov; 7(42):3838-43. PubMed ID: 714689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
    Whelton A
    Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminoglycoside tissue accumulation. A comparison between gentamycin and tobramycin in patients (author's transl)].
    Schentag JJ
    Nouv Presse Med; 1978 Nov; 7(42):3824-9. PubMed ID: 714685
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of netilmicin and other aminoglycosides on renal function. A survey of the literature on the nephrotoxicity of netilmicin.
    Dahlager JI
    Scand J Infect Dis Suppl; 1980; Suppl 23():96-102. PubMed ID: 7010549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dibekacin intrarenal distribution characteristics and renal cortical elution kinetics. Comparison with gentamicin and tobramycin.
    Whelton A; Carter GG; Stout RL; Herbst DV; Bryant HH; Walker G
    J Clin Pharmacol; 1980; 20(8-9):518-25. PubMed ID: 7430416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of gentamicin accumulation in severly diseased kidneys.
    Whelton A; Carter GG; Bryant HH; Fox L; Walker WG
    Arch Intern Med; 1976 Feb; 136(2):172-7. PubMed ID: 2129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside nephrotoxicity in dogs: dependence on drug, dose and regimen.
    Thompson WL; Powell S
    Scand J Infect Dis Suppl; 1980; Suppl 23():91-5. PubMed ID: 6937972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the intrarenal disposition of tobramycin and gentamicin: therapeutic and toxicologic answers.
    Whelton A; Carter GG; Craig TJ; Bryant HH; Herbst DV; Walker WG
    J Antimicrob Chemother; 1978 May; 4 Suppl A():13-22. PubMed ID: 26653
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
    Malis CD; Racusen LC; Solez K; Whelton A
    J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
    Fillastre JP; Hemet J; Tulkens P; Morin JP; Viotte G; Olier B; Godin M
    Adv Nephrol Necker Hosp; 1983; 12():253-75. PubMed ID: 6404138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simulation of the pharmacokinetics of aminoglycosides in the kidneys: single and continuous intake of sisomicin and gentamicin by rats].
    Firsov AA; Umnova LV; Fomina IP
    Antibiotiki; 1983 Nov; 28(11):826-34. PubMed ID: 6651271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
    Williams PD; Hottendorf GH; Bennett DB
    J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the cochleo-vestibular tolerance of several antibiotics of the aminoglycoside group].
    Conraux C
    Nouv Presse Med; 1978 Nov; 7(42):3856-8. PubMed ID: 309593
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney.
    Fabre J; Fillastre JP; Morin JP; Rudhardt M
    Contrib Nephrol; 1978; 10():53-62. PubMed ID: 668380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The nephrotoxic potential of cefalotin-aminoside antibiotic combinations (author's transl)].
    Carbon C; Rehfeld P; Lamotte-Barrillon S
    Nouv Presse Med; 1977 Sep; 6(30):2677-80. PubMed ID: 909755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased gentamicin nephrotoxicity in normal and diseased dogs administered identical serum drug concentration profiles: increased sensitivity in subclinical renal dysfunction.
    Frazier DL; Dix LP; Bowman KF; Thompson C; Riviere JE
    J Pharmacol Exp Ther; 1986 Dec; 239(3):946-51. PubMed ID: 3795053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.